Vimarsana
Biggest News Aggregation in the World

Page 45 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

Rural patients, physicians wait for full FDA approval to adopt new Alzheimer's drug - Vimarsana News

Rural patients, physicians wait for full FDA approval to adopt new Alzheimer's drug

Rural physicians and patients are waiting on the FDA's full approval before they prescribe and adopt, Leqembi to ensure Medicare covers it.

Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted - Vimarsana News

Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted

/PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance...

FDA Approves GSK's Arexvy, World's First RSV Vaccine For Older Adults - Vimarsana News

FDA Approves GSK's Arexvy, World's First RSV Vaccine For Older Adults

The U.S. Food and Drug Administration approved GSK Plc.'s (GSK.L, GSK) Arexvy, the world's first respiratory syncytial virus or RSV vaccine for older adults. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

FDA Approves Companion Diagnostic for Mobocertinib in Advanced NSCLC With EGFR Exon 20 Insertion Mutations - Vimarsana News

FDA Approves Companion Diagnostic for Mobocertinib in Advanced NSCLC With EGFR Exon 20 Insertion Mutations

The FDA has approved FoundationOne® Liquid CDx as a companion diagnostic for mobocertinib in patients with locally advanced or metastatic non–small cell lung cancer harboring EGFR exon 20 insertion mutations.

FDA Clears Centricity Vision's ZEPTOLink IOL Positioning System - Vimarsana News

FDA Clears Centricity Vision's ZEPTOLink IOL Positioning System

/PRNewswire/ -- Centricity Vision Inc., a global ophthalmic technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug...